nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids
|
Ramakrishna, Gayatri |
|
|
15 |
6 |
p. 1309-1317 |
artikel |
2 |
Are herbals more hepatotoxic than prescription medications?
|
Chen, Vincent L. |
|
|
15 |
6 |
p. 1301-1304 |
artikel |
3 |
A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?
|
Dong, Shujie |
|
|
15 |
6 |
p. 1356-1375 |
artikel |
4 |
Consensus on the secondary prevention of primary liver cancer
|
Nan, Yuemin |
|
|
15 |
6 |
p. 1289-1300 |
artikel |
5 |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng, Huei-Ru |
|
|
15 |
6 |
p. 1466-1467 |
artikel |
6 |
Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery
|
Özbaş, Burak |
|
|
15 |
6 |
p. 1442-1455 |
artikel |
7 |
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
|
Chon, Hye Yeon |
|
|
15 |
6 |
p. 1328-1336 |
artikel |
8 |
Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction
|
Nautiyal, Nidhi |
|
|
15 |
6 |
p. 1389-1401 |
artikel |
9 |
‘First week’ is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure
|
Choudhury, Ashok |
|
|
15 |
6 |
p. 1376-1388 |
artikel |
10 |
Gut microbiota alteration in hepatobiliary diseases: cause-and-effect relationship
|
Guo, Xiaoyan |
|
|
15 |
6 |
p. 1305-1308 |
artikel |
11 |
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis
|
Wu, Xiaoning |
|
|
15 |
6 |
p. 1318-1327 |
artikel |
12 |
Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease
|
Yoon, Ji Won |
|
|
15 |
6 |
p. 1347-1355 |
artikel |
13 |
Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury
|
Huang, Yi-Shin |
|
|
15 |
6 |
p. 1456-1465 |
artikel |
14 |
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
|
Meng, Fanping |
|
|
15 |
6 |
p. 1402-1412 |
artikel |
15 |
Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial
|
Shi, Ming |
|
|
15 |
6 |
p. 1431-1441 |
artikel |
16 |
Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study
|
Liu, Hui-Hui |
|
|
15 |
6 |
p. 1337-1346 |
artikel |
17 |
Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
|
Teng, Wei |
|
|
15 |
6 |
p. 1421-1430 |
artikel |
18 |
Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis
|
Yan, Lun-Jie |
|
|
15 |
6 |
p. 1413-1420 |
artikel |